- Research works
- 13 ▼ 100% vs 2018-21
- Citations
- 407 30.6 per fractional work
- Top-10% rate
- 13.8% all institutions 10.0%
- Open access
- 35% world 40%
- International
- 31% world 18%
Not ranked overall: Efamol (United Kingdom) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Efamol (United Kingdom) work in?
In all years, 72% of research at Efamol (United Kingdom) is in Health Sciences, 20% in Life Sciences. Its largest fields are Medicine (43%), Nursing (29%), Biochemistry, Genetics and Molecular Biology (20%). It does 2.1× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 10 fields, with their numbers
- Health Sciences1072.2%
- Life Sciences320.5%
- Physical Sciences16.1%
- Environmental Science01.7%
- Engineering01.3%
- Physics and Astronomy01.3%
- Earth and Planetary Sciences01.0%
- Chemistry00.8%
- Social Sciences01.3%
- Arts and Humanities01.3%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Efamol (United Kingdom) publish most on?
By volume: Fatty Acid Research and Health, Cholesterol and Lipid Metabolism, Eicosanoids and Hypertension Pharmacology and Diet and metabolism studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Fatty Acid Research and Health Nutrition and Dietetics 4 works
- 2 Cholesterol and Lipid Metabolism Surgery 1 works
- 3 Eicosanoids and Hypertension Pharmacology Biochemistry 1 works
- 4 Diet and metabolism studies Physiology 1 works
- 5 Peroxisome Proliferator-Activated Receptors Molecular Biology 1 works
- 6 Natural Antidiabetic Agents Studies Endocrinology, Diabetes and Metabolism 0 works
- 7 Exercise and Physiological Responses Rehabilitation 0 works
- 8 Salivary Gland Disorders and Functions Physiology 0 works
- 9 Folate and B Vitamins Research Rheumatology 0 works
- 10 Liver Disease Diagnosis and Treatment Epidemiology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Efamol (United Kingdom)'s research output changed?
Output in 2022-2025 was 100% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Efamol (United Kingdom) as a percentage of every work published that year, 0.0000095% in 2013.
Fractional works of Efamol (United Kingdom) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Wakefield
- Pinderfields Hospital
- Mid Yorkshire Hospitals NHS Trust
- West Yorkshire Police
- South West Yorkshire Partnership NHS Foundation Trust
- Yorkshire Ambulance Service NHS Trust
- Wakefield College
- The Howard Foundation
- Fieldhead Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Efamol (United Kingdom). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.